Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
May 08 2024 - 1:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of May 2024
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
Board Committee Change
GSK plc today announces the following changes to its Board
Committee membership:
Wendy Becker has been appointed as a member of the Corporate
Responsibility Committee with effect from 7 May 2024. As previously
announced, Wendy succeeded Urs Rohner as Chair of the Remuneration
Committee following his retirement from the Board at the conclusion
of the 2024 Annual General Meeting held today.
These changes are in addition to Wendy's membership of the Audit
& Risk Committee.
V A Whyte
Company Secretary
8 May 2024
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
|
GSK plc
|
|
|
(Registrant)
|
|
|
|
|
Date: May
8, 2024
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GSK plc
|
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From Apr 2024 to May 2024
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From May 2023 to May 2024
